Ameriprise’s Fibrocell Science Inc. FCSC Stock Holding History

Ameriprise’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-70	Closed	-$5K	–	5535
2013 Q3	$5K	Hold	70	–	–	﹤0.01%	5246
2013 Q2	$6K	Buy	+70	New	+$5.79K	﹤0.01%	5087

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's FCSC Position: Q4 2013 in Review

Ameriprise sold out of Fibrocell Science Inc. (FCSC) in Q4 2013, closing a stake of 70 shares — an estimated $5K sold.

Ameriprise first reported a position in FCSC in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q2 2013. 43 funds tracked by Wall St. Rank hold FCSC as of Q4 2013.

Ameriprise reported no remaining Fibrocell Science Inc. position as of Q4 2013 after selling out during the quarter.
Ameriprise sold 70 Fibrocell Science Inc. shares in Q4 2013, an estimated $5K.
Ameriprise first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 2 quarters.
Ameriprise's Fibrocell Science Inc. position peaked at $6K in Q2 2013.
43 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2013.

Based on Ameriprise's 13F filing for Q4 2013, filed 14 Feb 2014.